|Day Low/High||83.21 / 83.82|
|52 Wk Low/High||71.03 / 89.27|
The medical device company taps Jason Hannon, an 11-year company veteran, as its new president and COO, succeeding Patrick Miles, who was appointed vice chairman.
In the last year, shares of Boston Scientific are up almost 50%. Boston Scientific is putting the problems of the past behind it and has a bright future.
Edwards Lifesciences is one of the best-performing stocks in the health care sector. Year to date, the stock is up 47%. Can it continue to climb?
The most recent short interest data has been released for the 08/15/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
Medtronic (MDT) posted solid earnings for the 2017 fiscal first quarter before Thursday's market open.
The Fed meets for a monetary policy summit, and investors consider dollar-store earnings and jobless claim numbers.
Here are Thursday's top research calls, including upgrades for Citigroup, GameStop and Transocean, and an earnings-estimate increase for Medtronic.
Medtronic (MDT) is slated to report 2017 first quarter earnings and revenue before tomorrow's market open.
Here are Tuesday's top research calls, including an upgrade for Square and new coverage of Chipotle Mexican Grill, Darden Restaurants and McDonald's.
This medical device maker is positioned to profit from global demographic trends.
TheStreet highlights 3 stocks pushing the health care sector higher today.
Stocks with insider trader activity include WDAY, TIPT and MDT
Can medical technology stocks continue their momentum higher in the second half of the year? Investors say yes, but technical analysis says not necessarily.
Trade-Ideas LLC identified Medtronic (MDT) as a new lifetime high candidate
Goldman Sachs expects "rising uncertainty" in the second half of 2016 and suggests that investors stick to stocks within defensive sectors including consumer, health care and telecom services.
The eventual negative implications of Brexit could be greater for health care companies that have sizable exposure to Europe.
Engaged Capital agitated against the cardiac medical device maker's buy of an Israeli company and pushed for a new board member that once led the acquirer's M&A efforts.
TheStreet’s Jim Cramer said Medtronic’s (MDT) $1.1 billion proposed acquisition of HeartWare (HTWR) is a 'home run.'
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer said Medtronic's $1.1 billion proposed acquisition of HeartWare International on Monday is a smart deal.
U.S. stocks extended their declines, piling on heavy losses suffered at the end of last week, as markets continued to react to the pro-exit vote from the U.K.
Stock losses accelerate by late morning Monday as the fallout from Friday's 'Brexit' vote punishes global markets.
Medtronic started its drive after buying Covidien and switching its tax base to Ireland. Now it's buying Heartware International, Cramer says.
Medtronic (MDT) stock is lower in early-morning trading on Monday after agreeing to purchase HeartWare for roughly $1.1 billion.
Stock futures point to another day in the red on Monday, piling on heavy losses suffered at the end of last week.
Medtronic is raising its quarterly dividend by 13 percent to $0.43 a share.